Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection.
In felids, feline leukemia virus (FeLV) infection results in a variety of outcomes that range from abortive (virus readily eliminated and never detectable) to progressive infection (persistent viremia and viral shedding). Recently, a novel outcome was postulated for low FeLV infectious doses. Naïve cats exposed to faeces of persistently infected cats seroconverted, indicating infection, but remained negative for provirus and p27 antigen in blood. FeLV provirus was found in some tissues but not in the bone marrow, infection of which is usually considered a necessary stage for disease progression. To investigate the impact of low FeLV doses on young cats and to test the hypothesis that low dose exposure may lead to an unknown pathogenesis of infection without involvement of the bone marrow, 21 cats were infected oronasally with variable viral doses. Blood p27, proviral and viral loads were followed until week 20 post-infection. Tissue proviral loads were determined as well. The immune response was monitored by measuring FeLV whole virus and p45 antibodies; and feline oncornavirus-associated cell membrane antigen (FOCMA) assay. One cat showed regressive infection (transient antigenemia, persistent provirus-positivity, and seroconversion) with provirus only found in some organs at sacrifice. In 7 of the 20 remaining cats FOCMA assay positivity was the only sign of infection, while all other tests were negative. Overall, the results show that FeLV low dose exposure can result in seroconversion during a presumed abortive infection. Therefore, commonly used detection methods do not detect all FeLV-infected animals, possibly leading to an underestimation of the prevalence of infection.
Major
Andrea
A
Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland.
Cattori
Valentino
V
Boenzli
Eva
E
Riond
Barbara
B
Ossent
Peter
P
Meli
Marina Luisa
ML
Hofmann-Lehmann
Regina
R
Lutz
Hans
H
D000818:Animals; D000914:Antibodies, Viral; D002371:Cat Diseases / Q000276:immunology* / Q000821:virology; D002415:Cats; D004279:DNA, Viral / Q000097:blood; D005256:Leukemia Virus, Feline; D008297:Male; D018809:Proliferating Cell Nuclear Antigen / Q000097:blood; D012367:RNA, Viral / Q000097:blood; D012192:Retroviridae Infections / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D013047:Specific Pathogen-Free Organisms; D014412:Tumor Virus Infections / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D019562:Viral Load
D000914:Antibodies, Viral; D004279:DNA, Viral; D018809:Proliferating Cell Nuclear Antigen; D012367:RNA, Viral; C413374:p27 antigen